U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07050173) titled 'Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation' on June 20.
Brief Summary: The goal of this clinical trial is to test whether the gamma - glutamylcystiene (GGC) oral supplement can reach the brain and subsequently increase antioxidant glutathione level in people with repetitive head injury (RHI). This will reduce the oxidative stress related injury in people with RHI.This unique study's main objective is to test the:
1. Change in Glutathione (GSH) in brain and blood levels.
2. Change in the cognitive function in RHI patients.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condi...